Identification of a novel IL-5 signaling pathway in chronic pancreatitis and crosstalk with pancreatic tumor cells

SB Gitto, JM Beardsley, SP Nakkina, JL Oyer… - Cell Communication and …, 2020 - Springer
Background While inflammation is associated with pancreatic cancer, the underlying
mechanisms leading to cancer initiation are still being delineated. Eosinophils may promote …

[HTML][HTML] Interleukin 22 signaling regulates acinar cell plasticity to promote pancreatic tumor development in mice

MP Lanfranca, Y Zhang, A Girgis, S Kasselman… - Gastroenterology, 2020 - Elsevier
Background & Aims Pancreatic ductal adenocarcinoma (PDAC) is an aggressive
malignancy that invades surrounding structures and metastasizes rapidly. Although …

IL22RA1/STAT3 signaling promotes stemness and tumorigenicity in pancreatic cancer

W He, J Wu, J Shi, YM Huo, W Dai, J Geng, P Lu… - Cancer research, 2018 - AACR
Chronic inflammation is a feature of pancreatic cancer, but little is known about how immune
cells or immune cell–related signals affect pancreatic cancer stemness and development …

Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance

Y Zhang, W Yan, MA Collins, F Bednar, S Rakshit… - Cancer research, 2013 - AACR
Pancreatic cancer, one of the deadliest human malignancies, is almost invariably associated
with the presence of an oncogenic form of Kras. Mice expressing oncogenic Kras in the …

Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition

I Siddiqui, M Erreni, MA Kamal, C Porta… - …, 2018 - Taylor & Francis
ABSTRACT K-Ras mutations are a hallmark of human pancreatic adenocarcinoma (PDAC)
and epithelial-mesenchymal-transition (EMT) is a driver of progression. Oncogenic K-Ras …

Interleukin-6: a villain in the drama of pancreatic cancer development and progression

R Holmer, FA Goumas, GH Waetzig… - … & Pancreatic Diseases …, 2014 - Elsevier
Background Pancreatic ductal adenocarcinoma (PDAC) is a devastating malignancy with a
poor prognosis and little treatment options. The development and progression of the disease …

Emerging roles for the IL-6 family of cytokines in pancreatic cancer

G van Duijneveldt, MDW Griffin, TL Putoczki - Clinical science, 2020 - portlandpress.com
Pancreatic cancer has one of the poorest prognoses of all malignancies, with little
improvement in clinical outcome over the past 40 years. Pancreatic ductal adenocarcinoma …

IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells

LW Feurino, Y Zhang, U Bharadwaj… - Cancer biology & …, 2007 - Taylor & Francis
BACKGROUND. Although upregulation of interleukin-6 (IL-6) is associated with many solid
tumors, its role in pancreatic cancer has not been well elucidated. In this study, we examined …

The presence of interleukin-13 at pancreatic ADM/PanIN lesions alters macrophage populations and mediates pancreatic tumorigenesis

GY Liou, L Bastea, A Fleming, H Döppler, BH Edenfield… - Cell reports, 2017 - cell.com
The contributions of the innate immune system to the development of pancreatic cancer are
still ill defined. Inflammatory macrophages can initiate metaplasia of pancreatic acinar cells …

Blocking IL-6/GP130 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity in human pancreatic cancer cells

X Chen, J Tian, GH Su, J Lin - Current cancer drug targets, 2019 - ingentaconnect.com
Background: Elevated production of the pro-inflammatory cytokine interleukin-6 (IL-6) and
dysfunction of IL-6 signaling promotes tumorigenesis and are associated with poor survival …